03:53 PM EST - Cardiome Pharma Corp. : said its third-quarter net loss narrowed to $400,000 or $0.01 per share from $11.8 million or $0.18 per share in the prior-year period. Research and development expenditures for the quarter increased to $10.3 million from $8.5 million in the comparable period. Cardiome Pharma Corp.
shares T.COM are trading down $0.10 at $4.34.
